SE7509123L - 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma. - Google Patents

3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.

Info

Publication number
SE7509123L
SE7509123L SE7509123A SE7509123A SE7509123L SE 7509123 L SE7509123 L SE 7509123L SE 7509123 A SE7509123 A SE 7509123A SE 7509123 A SE7509123 A SE 7509123A SE 7509123 L SE7509123 L SE 7509123L
Authority
SE
Sweden
Prior art keywords
same
methylpyrazole
carboxylate
preparing
methods
Prior art date
Application number
SE7509123A
Other languages
English (en)
Inventor
G Brenner
K Credner
J Goring
M Tauscher
Original Assignee
Wuelfing J A Fa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuelfing J A Fa filed Critical Wuelfing J A Fa
Publication of SE7509123L publication Critical patent/SE7509123L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
SE7509123A 1974-08-14 1975-08-14 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma. SE7509123L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2439137A DE2439137A1 (de) 1974-08-14 1974-08-14 3-methyl-pyrazol-5-carboxylate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Publications (1)

Publication Number Publication Date
SE7509123L true SE7509123L (sv) 1976-02-16

Family

ID=5923236

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7509123A SE7509123L (sv) 1974-08-14 1975-08-14 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.

Country Status (12)

Country Link
US (1) US3980646A (sv)
JP (1) JPS51104019A (sv)
AR (1) AR211100A1 (sv)
AT (1) AT338287B (sv)
BE (1) BE832389A (sv)
CA (1) CA1062258A (sv)
DE (1) DE2439137A1 (sv)
FI (1) FI752070A (sv)
FR (1) FR2281758A1 (sv)
GB (1) GB1481147A (sv)
NL (1) NL7509706A (sv)
SE (1) SE7509123L (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092417A (en) * 1976-12-08 1978-05-30 Johann A. Wulfing Theophylline salts of 5-methylisoxazole-3-carboxylic acid
FR2373283A1 (fr) * 1976-12-10 1978-07-07 Wuelfing Johann A Composes derives de l'isoxazole, utilisables comme medicament
AU2003300014A1 (en) * 2002-10-10 2004-05-04 Arena Pharmaceuticals, Inc. 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia
EP1633351A1 (en) * 2003-06-13 2006-03-15 Arena Pharmaceuticals, Inc. 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
JP4348440B2 (ja) 2005-09-01 2009-10-21 有洙 安 透過性補強材と発泡体を利用したベッド用マットレス及びその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2924598A (en) * 1960-02-09 Methods of preparing same
DE1089763B (de) * 1957-10-26 1960-09-29 Wuelfing J A Fa Verfahren zur Herstellung des 7-[ª‰-Oxy-ª†-(methyl-ª‰-oxyaethylamino)-propyl]-theophyllin-nikotinats
DE1102750B (de) * 1958-07-17 1961-03-23 Wuelfing J A Fa Verfahren zur Herstellung eines Salzes von Theophyllinbasen
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
AT313916B (de) * 1971-10-28 1974-03-11 Degussa Verfahren zur Herstellung von neuen basisch substituierten Theophyllinen und deren Säureadditionssalzen

Also Published As

Publication number Publication date
ATA618075A (de) 1976-12-15
DE2439137A1 (de) 1976-08-12
NL7509706A (nl) 1976-02-17
BE832389A (fr) 1976-02-13
AT338287B (de) 1977-08-10
GB1481147A (en) 1977-07-27
CA1062258A (en) 1979-09-11
FI752070A (sv) 1976-02-15
AR211100A1 (es) 1977-10-31
JPS51104019A (en) 1976-09-14
US3980646A (en) 1976-09-14
FR2281758B1 (sv) 1978-09-08
FR2281758A1 (fr) 1976-03-12

Similar Documents

Publication Publication Date Title
SE7507414L (sv) Galenisk beredning.
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NL7512732A (nl) Nieuwe heterocyclische verbindingen, de bereiding ervan en preparaten die de nieuwe verbindingen bevatten.
NL7510342A (nl) Gesubstitueerde purineverbindingen en farmaceu- tische toepassing daarvan.
SE7509030L (sv) Bensoylureido-difenyletrar till anvendning som insekticider och sett for deras framstellning.
NL7500552A (nl) Farmaceutische preparaten.
NL7510535A (nl) Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7506101A (nl) Copolyamidepreparaten.
SE7508544L (sv) Bensimidazol-derivat och sett att framstella desamma.
NL7514858A (nl) Beschermend kinkhoest-antigeen, zijn bereiding en preparaten daarvan.
NL7514337A (nl) Oxydiaceetaldehyde bevattende preparaten en werk- wijzen ter bereiding ervan.
SE7511438L (sv) 7-hydroxi-ostradioler och sett att framstella desamma
SE7507238L (sv) Sampolymerisat, och forfarande for deras framstellning och anvendning.
NL7510259A (nl) Uridinederivaat alsmede farmaceutisch preparaat.
SE7509123L (sv) 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.
NL7508706A (nl) Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
SE7514344L (sv) 3-fluorobensodiazepiner och forfarande for framstellniing derav
NL7505009A (nl) Preparaten.
NL7514113A (nl) Werkwijze ter bereiding van farmaceutische prepa- raten, gevormde farmaceutische preparaten, alsme- de werkwijze ter bereiding van nieuwe cefemverbin- dingen.
NL7501362A (nl) Anti-parkinson-verbindingen en - preparaten.
NL7505174A (nl) Farmaceutische mengsels.
NL7500767A (nl) Pigmentpreparaten.
SE7513298L (sv) Diaryloxi-imidazolyl-o,n-acetaler till anvendning som lekemedel och sett for deras framstellning
NL7704084A (nl) Medicinale preparaten.
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid